Cambridge Investment Research Advisors »

Immunic shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Immunic shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Immunic

Tip: Access up to 7 years of quarterly data

All positions including Immunic held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunic by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $54k 49k 1.11

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Microsoft Corp Com (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Alphabet Inc Cap Stk Cl A (GOOGL)
Alphabet Inc Cap Stk Cl C (GOOG)
SPDR Gold Tr Gold Shs (GLD)

View all positions for Cambridge Investment Research Advisors

Top funds holding Immunic

Standard Life Aberdeen
BVF
Avidity Partners Management
Vanguard Capital Management
Soleus Capital Management
Laurion Capital Management
Millennium Management
Morgan Stanley
Nantahala Capital Management
683 Capital Management
Propel Bio Management
Geode Capital Management
Adage Capital Partners GP
Susquehanna International
Woodline Partners

View all funds holding Immunic